Ignite Creation Date:
2025-12-24 @ 11:45 AM
Ignite Modification Date:
2026-01-02 @ 10:28 PM
Study NCT ID:
NCT01684761
Status:
COMPLETED
Last Update Posted:
2017-01-10
First Post:
2012-09-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
Sponsor:
Opexa Therapeutics, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Protocol Number 2012-00
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None